Restoration of a tumorigenic phenotype by β2-microglobulin transfection to EL-4 mutant cells

64Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

It has frequently been suggested that loss of β2-microglobulin (β2m) in tumor cells may lead to malignant progression due to escape from immunological recognition. Here, we directly tested the role of β2m expression in tumorigenicity. A β2m loss mutant (C4.4-25-), selected from the murine lymphoma EL-4, showed a marked reduction in tumorigenicity as compared with EL-4 in normal C57B1/6 (B6) mice. The reduced tumorigenicity was directly related to β2m expression. Transfection of an intact murine β2m gene markedly increased the tumorigenic potential. The reduced tumorigenicity of C4.4-25- compared with β2m transfected cells was observed also in athymic B6 nu/nu mice, but was abolished in B6 mice depleted of natural killer (NK) 1.1-positive cells. These results show that restoration of β2m expression can promote tumorigenicity and demonstrate for the first time that induction of major histocompatibility complex class I expression by transfection can lead to escape from NK cells in vivo.

Cite

CITATION STYLE

APA

Glas, R., Sturmhöfel, K., Hämmerling, G. J., Karre, K., & Ljunggren, H. G. (1992). Restoration of a tumorigenic phenotype by β2-microglobulin transfection to EL-4 mutant cells. Journal of Experimental Medicine, 175(3), 843–846. https://doi.org/10.1084/jem.175.3.843

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free